Full Text View
Tabular View
No Study Results Posted
Related Studies
Lupus Nephritis: Role of Environmental and Occupational Exposures
This study has been completed.
First Received: June 19, 2006   Last Updated: March 5, 2008   History of Changes
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00342329
  Purpose

The purpose of this study is to examine hormonal and environmental risk factors (and possible gene-environmental interactions) involved in the etiology of lupus nephritis. Our study will focus on exposures to occupational and environmental agents that have been linked to the development of systemic lupus erythematosus (SLE) or renal disease (e.g., silica dust, smoking). We will also assess potential gene environment interactions. We will examine these exposures in 100 patients with renal biopsy with documented proliferative or membraneous nephritis. We will compare exposures in the lupus nephritis patients to lupus patients who do not have nephritis and to normal controls who have participated in the Carolina Lupus Study. One hundred lupus nephritis patients (age 18 years or older, of both genders and all races) will be identified through the Glomerular Disease Collaborative Network (GDCN) Nephropathology database and participating nephrologists at the Medical University of South Carolina, Duke University Medical Center and the East Carolina Medical School.


Condition
Lupus Nephritis

Study Type: Observational
Official Title: Lupus Nephritis: Role of Environmental and Occupational Exposures

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 0
Study Start Date: April 2001
Estimated Study Completion Date: March 2007
Detailed Description:

The purpose of this study is to examine hormonal and environmental risk factors (and possible gene-environmental interactions) involved in the etiology of lupus nephritis. Our study will focus on exposures to occupational and environmental agents that have been linked to the development of systemic lupus erythematosus (SLE) or renal disease (e.g., silica dust, smoking). We will also assess potential gene environment interactions. We will examine these exposures in 100 patients with renal biopsy with documented proliferative or membraneous nephritis. We will compare exposures in the lupus nephritis patients to lupus patients who do not have nephritis and to normal controls who have participated in the Carolina Lupus Study. One hundred lupus nephritis patients (age 18 years or older, of both genders and all races) will be identified through the Glomerular Disease Collaborative Network (GDCN) Nephropathology database and participating nephrologists at the Medical University of South Carolina, Duke University Medical Center and the East Carolina Medical School.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Have renal biopsy proven Lupus Nephritis (with the biopsy-based diagnosis date no earlier than January 1, 1995).

Reside within designated counties of eastern North Carolina and South Carolina.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00342329

Locations
United States, North Carolina
University of North Carolina
Chapel Hill, North Carolina, United States, 27599-7030
NIEHS, Research Triangle Park
Research Triangle Park, North Carolina, United States, 27709
Sponsors and Collaborators
  More Information

No publications provided

Study ID Numbers: 999901154, 01-E-N154
Study First Received: June 19, 2006
Last Updated: March 5, 2008
ClinicalTrials.gov Identifier: NCT00342329     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Case-Control
Hydrocarbons
Metals
Silica
Tobacco Smoke
Lupus Nephritis
Environmental Exposures
Occupational Exposures

Additional relevant MeSH terms:
Glomerulonephritis
Autoimmune Diseases
Immune System Diseases
Lupus Erythematosus, Systemic
Urologic Diseases
Lupus Nephritis
Nephritis
Connective Tissue Diseases
Kidney Diseases

ClinicalTrials.gov processed this record on November 27, 2009